The purpose of this research study is to determine if lattice radiation therapy (LRT) will provide better treatment for bulky (large) tumors than current stand…

CancerMetastatic CancerLocally Advanced+2 more

~Estimated

~$10 – $5,625

University of CincinnatiNCT06416007

Phase 1

A Phase 1a/1b Study of the Selective Tyrosine Kinase Inhibitor NVL-330 in Patients With Advanced or Metastatic HER2-altered NSCLC (HEROEX-1)

Phase 1a/1b dose escalation and expansion study designed to evaluate the safety and tolerability of NVL-330, determine the recommended Phase 2 dose (RP2D), and…

Locally Advanced Solid TumorMetastatic Solid Tumor

~Estimated

~$10 – $8,750

Nuvalent Inc.NCT06521554

← PreviousPage 2 of 2Next →